Neuroblastoma Screening (PDQ®)–Patient Version
Neuroblastoma screening does reduce the chance of dying from the disease. Not all screening tests are helpful and most have risks. Learn more about neuroblastoma and the potential benefits and harms of screening in this expert-reviewed summary.
Media Type: Html
- SourceUrl: https://www.cancer.gov/node/2497/syndication
- Syndication ID: 1429
- Language: English
- Source: National Cancer Institute (NCI)
- Date Syndication Captured: Saturday, September 14, 2013 at 09:00 AM
- Date Syndication Updated: Monday, August 05, 2019 at 07:41 PM
Tags
General:
screening
patient
version
neuroblastoma
disease screening
Embed Code Snippet
To get the embed code snippet please Login.
